hC Bioscience Announces $24 Million Series A Financing to

Combining a strong syndicate of investors, seasoned management, and exemplary scientific advisorshC Bioscience is developing a new class of therapy for...

Related Keywords

New York ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,San Francisco ,California ,Ottawa ,Ontario ,Canada ,University Of Rochester ,Leslie Williams ,David Moskowitz ,Steven Gillis ,Craig Mello ,Jeff Bockman ,Sacha Mann ,Oladapo Yeku ,Selecta Biosciences ,David Altreuter ,Christopher Ahern ,Andrew Mielach ,John Bell ,Lesliej Williams ,Chris Ahern ,John Lueck ,John Dipersio ,National Centre Of Excellence ,Head Of Research ,Linkedin ,Umass Medical Center ,University Of Iowa ,Cello Health ,Department Of Molecular Physiology ,University Of Ottawa ,Washington University ,Takeda Ventures Inc ,Harvard University ,C Bioscience Inc ,Professor At University Of Rochester ,Early Development Of Novartis Gene Therapies ,Takeda Ventures ,Professor Christopher Ahern ,Assistant Professor ,Lyndra Therapeutics ,Scientific Advisory Board ,Medical Center ,Page Bouchard ,Early Development ,Novartis Gene Therapies ,Scientific Director ,National Centre ,Cancer Therapy ,Oncology Practice ,Molecular Physiology ,Hc Bioscience ,Nc ,